Who is the CEO of ACTU? | Glauxie AI

Q: Who is the CEO of ACTU?

Actuate Therapeutics Inc (ACTU) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Daniel Schmitt. Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of cancers. The company's lead product candidate is Elraglusib Injection, a... Employees: 200,000.

Q: What does ACTU company do?

Learn what ACTU does — business model, products, services, revenue segments, and company history.

Q: Are insiders buying or selling ACTU?

Track recent insider buys and sells for ACTU with transaction details, amounts, and trends.

Q: What sector is ACTU in?

Find ACTU sector, industry, and sub-industry classification with sector peer comparison.

Who is the CEO of ACTU?

🦉

Actuate Therapeutics Inc (ACTU)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEODaniel Schmitt

Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of cancers. The company's lead product candidate is Elraglusib Injection, a novel glycogen synthase kinase-3 inhibitor to treat metastatic pancreatic ductal adenocarcinoma. It...

Key Executives

Name	Title
Alan Kozikowski	Scientific Founder and Advisor
Andrew Mazar	Co-Founder & Chief Operating Officer
Daniel Schmitt	Chief Executive Officer, President & Director
Paul J. Lytle	Chief Financial Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

ACTU Profile Financials

What does ACTU company do? Are insiders buying or selling ACTU? What sector is ACTU in?